-

Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%

Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Ardent Health, Inc. (“Ardent Health”) plummeted over 33% in intraday trading on November 13, 2025, after the company reported a $43 million decrease in revenue following recent “hindsight evaluations of historical collection trends,” along with a $54 million rise in its professional liability reserves. Gibbs Mura is investigating a potential Ardent Health, Inc. (NYSE: ARDT) Securities Class Action Lawsuit for investors over the company’s possible violations of federal securities laws.

INVESTED IN ARDT?

VISIT OUR ARDENT HEALTH, INC. LAWSUIT INVESTIGATION OR CALL (888) 410-2925 TO LEARN HOW YOU MAY BE ABLE TO RECOVER YOUR LOSSES.

What is the Ardent Health, Inc. Investigation About?

On November 12, 2025, Ardent Health announced its Q3 financial results for 2025, revealing a $43 million drop in revenue. The company attributed the decline to new information from recent “hindsight evaluations of historical collection trends” and adjustments to the technique the company uses to estimate the collectability of its accounts receivable. Ardent Health also reported a $54 million rise in its professional liability reserves due in part to “adverse prior period claim developments,” which stemmed from recent settlements and active litigation in New Mexico.

Following this news, shares of Ardent Health plummeted over 33% on November 13, 2025, causing significant harm to investors.

About Gibbs Mura, A Law Group

Gibbs Mura represents investors nationwide in securities litigation and cases involving financial fraud. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous awards for their work, including “Class Action Practice Group of the Year,” “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

PRESS CONTACT: CATHERINE CONROY
PHONE: 510.350.9705
EMAIL: CRC@CLASSLAWGROUP.COM

Gibbs Mura

NYSE:ARDT

Release Summary
Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Ardent Health, Inc. (NYSE: ARDT) investors.
Release Versions
$Cashtags

Contacts

PRESS CONTACT: CATHERINE CONROY
PHONE: 510.350.9705
EMAIL: CRC@CLASSLAWGROUP.COM

More News From Gibbs Mura

Richtech Robotics Inc. Under Investigation After 20% Stock Drop

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Richtech Robotics Inc. (“Richtech Robotics”) fell over 20% in intraday trading on January 29, 2026, after Hunterbrook Media published a report accusing the company of misrepresenting its “collaboration” with Microsoft and missing its 10-K extended filing deadline. Gibbs Mura is investigating a potential Richtech Robotics Inc. (NASDAQ: RR) Securities Class Action Lawsuit concerning whether Richtech Robotics has violated federal securities laws by provi...

Kaiser Agrees To Historic $556 Million To Settle Whistleblower Lawsuit Over Alleged Medicare Fraud

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is pleased to announce that Kaiser Permanente has agreed to pay $556 million to resolve allegations of Medicare Advantage risk-adjustment fraud. This is believed to be the largest Medicare Part C qui tam settlement ever reached, and is one of the largest whistleblower settlements brought under the False Claims Act settlements in recent years. Our firm’s client, Ronda Osinek was the first whistleblower to file a complaint against Kaiser in the long-ru...

Lost Money in Rezolve AI (RZLV)? Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Rezolve AI (NASDAQ: RZLV) investors....
Back to Newsroom